161 results on '"Wester, Hans-Juergen"'
Search Results
2. 68Ga-Pentixafor PET/MRI for Treatment Response Assessment in Mantle Cell Lymphoma: Comparison Between Changes in Lesion CXCR4 Expression on PET and Lesion Size and Diffusivity on MRI
3. Dissecting the target leukocyte subpopulations of clinically relevant inflammation radiopharmaceuticals
4. Clinical Molecular Imaging of Pulmonary CXCR4 Expression to Predict Outcome of Pirfenidone Treatment in Idiopathic Pulmonary Fibrosis
5. Evaluation of asymmetric orthogonal cyanine fluorophores
6. PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy
7. Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach
8. Automated synthesis of [18F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productions
9. Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate Cancer
10. Radiosynthesis and pre-clinical evaluation of [68Ga] labeled antimicrobial peptide fragment GF-17 as a potential infection imaging PET radiotracer
11. PSMA-Targeted Radiopharmaceuticals for Imaging and Therapy
12. Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer
13. 99mTechnetium-based Prostate-specific Membrane Antigen–radioguided Surgery in Recurrent Prostate Cancer
14. Consensus on molecular imaging and theranostics in prostate cancer
15. Chemokine receptor – Directed imaging and therapy
16. Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
17. Systemic Radioligand Therapy with 177Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer
18. Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
19. P-173 - Development and First-in-Man Study of a Novel Tetrapeptidic CCK-2R-Targeted Compound with Improved Metabolic Stability and Pharmacokinetics
20. P-129 - Preclinical Evaluation of [18F]F-[natLu]Lu-DOTA-rhCCK-18, the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with high Target Affinity and Tumor Accumulation
21. Volumetric Analysis of F-18-FET-PET Imaging for Brain Metastases
22. PET/CT Imaging of Integrin αvβ3 Expression in Human Carotid Atherosclerosis
23. Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma
24. Cationic eluate pretreatment for automated synthesis of [68Ga]CPCR4.2
25. Impact of 68Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy
26. Be spoilt for choice with radiolabelled RGD peptides: Preclinical evaluation of 68 Ga-TRAP(RGD)3
27. 68 Ga-Pentixafor PET/MRI for Treatment Response Assessment in Mantle Cell Lymphoma: Comparison Between Changes in Lesion CXCR4 Expression on PET and Lesion Size and Diffusivity on MRI.
28. Diet intervention reduces uptake of αvβ3 integrin-targeted PET tracer 18F-galacto-RGD in mouse atherosclerotic plaques
29. Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay
30. CXCR4-Targeted Imaging of Post-Infarct Myocardial Tissue Inflammation: Prognostic Value After Reperfused Myocardial Infarction
31. CXCR4 PET/MRI for follow-up of gastric mucosa–associated lymphoid tissue lymphoma after first-line Helicobacter pylori eradication
32. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients
33. A facile direct nucleophilic synthesis of O-(2-[18F]fluoroethyl)-l-tyrosine ([18F]FET) without HPLC purification
34. Clinical severity of Alzheimer's disease is associated with PIB uptake in PET
35. Molecular imaging of proliferation in vivo: Positron emission tomography with [ 18F]fluorothymidine
36. Molecular imaging targeting peptide receptors
37. Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid
38. Restricted Water Diffusibility as Measured by Diffusion-weighted MR Imaging and Choline Uptake in 11C-Choline PET/CT are Correlated in Pelvic Lymph Nodes in Patients with Prostate Cancer
39. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer’s disease
40. [ 11C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer
41. Radiochemical 18F-fluoroarylation of unsaturated α-, β- and γ-amino acids, application to a radiolabelled analogue of baclofen
42. PET/CT with Gluc-Lys-([18F]FP)-TOCA: correlation between uptake, size and arterial perfusion in somatostatin receptor positive lesions
43. Imaging of angiogenesis in cardiology
44. Preferred transport of O-(2-[ 18F]fluoroethyl)- d-tyrosine ( d-FET) into the porcine brain
45. High opiate receptor binding potential in the human lateral pain system
46. Chemoselective hydrazone formation between HYNIC-functionalized peptides and 18F-fluorinated aldehydes
47. Towards NR2B receptor selective imaging agents for PET—synthesis and evaluation of N-[ 11C]-(2-methoxy)benzyl ( E)-styrene-, 2-naphthyl- and 4-trifluoromethoxyphenylamidine
48. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
49. Positron emission tomography as a tool for translational research in oncology
50. Central poststroke pain and reduced opioid receptor binding within pain processing circuitries: a [ 11C]diprenorphine PET study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.